ArticleScientific reports2018

Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide).

Arshad A Pandith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.